Investor's Business Daily on MSN
Travere Therapeutics stock skyrockets on highly anticipated FDA approval
Travere Therapeutics stock jumped early Tuesday after the FDA approved Filspari for a new kidney disease.
Recent health news highlights significant regulatory and technological advancements in the medical field. South Korea bans syringe stockpiling due to supply concerns amid the Iran conflict, while U.S.
Investor's Business Daily on MSN
Big pharma deepens AI ties. What it means for Novo, Novartis.
Novo Nordisk and Novartis deepened their ties to AI companies on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results